Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05593484 · ClinicalTrials.gov registry record · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska
A NA study of Hearing Loss, sponsored by University of Arkansas.
- Recruiting
- Registry status
- NA
- Development phase
- 8,060
- Enrollment target
- 1
- Study location
NCT05593484: Recruiting NA study of Hearing Loss, sponsored by University of Arkansas.
NCT05593484 is a NA study of Hearing Loss that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 8,060 participants, above the 5,982-participant average among 58 other Hearing Loss trials with a reported enrollment target (35% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05593484, a NA study of Hearing Loss, is actively recruiting participants, sponsored by University of Arkansas.
- RECRUITING
- Registry status
- NA
- Development phase
- 8,060 participants
- Enrollment target
- 1
- Study location
Study Summary
The prevalence of childhood hearing loss in rural Alaska is disproportionately high and predominately infection-related. With preventive screenings and access to health care, much of childhood hearing loss is preventable. Although state-mandated school screening helps identify children with hearing loss, loss to follow-up is pervasive and exacerbated by a scarcity of specialists in rural regions. A mixed methods cluster randomized trial conducted in northwest Alaska demonstrated that telemedicine can significantly reduce loss to follow-up. This stepped wedge trial, in partnership with Southcentral Foundation, will build on this existing work to develop a model that can be scaled in diverse environments. We will adapt and implement a new telemedicine intervention called Specialty Telemedicine Access for Referrals (STAR). This trial will be conducted in 3 regions in rural Alaska that represent multiple healthcare systems. Based on stakeholder feedback and evidence generated from the previous trial, an enhanced mobile health (mHealth) hearing screening will be implemented in all participating schools prior to the STAR intervention, and the telemedicine referral to specialty care (STAR intervention) will be moved from the clinic directly into the school. This stepped-wedge cluster randomized trial is part of a larger hybrid type 1 effectiveness-implementation trial. The stepped wedge trial will evaluate the effectiveness of the STAR intervention in reducing loss to follow-up from referred school hearing screening in 3 regions of Alaska: Kodiak, Petersburg and Lower Yukon (n=23 schools, \~2,015 K-12 students/year). The STAR Intervention will be compared to the standard referral of a letter home to families. Cluster randomization at the level of school will be performed, with schools (clusters) randomized to one of two sequences. The effectiveness outcome (i.e., proportion of children who receive follow-up) will be evaluated over three academic years (2023-2026), with S
Primary Outcome
This outcome will be measured each school year, for 4 years, based on the updated timeline.
Conditions Studied
Interventions
- OTHER Standard Referral
- OTHER Specialty Telemedicine Access for Referrals (STAR)
Study Locations (1)
Alaska
- Southcentral Foundation - Anchorage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,060 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT05593484 shows while recruiting
NCT05593484 is an interventional study that assigns participants to a tested intervention. Its 8,060 participants enrollment target places it among the larger protocols in the corpus, above the 5,982-participant average among 58 other Hearing Loss trials with a reported enrollment target (35% higher).
The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Standard Referral is the first listed.
NCT05593484 reports a single indexed study location in Alaska.
Frequently Asked Questions
What is clinical trial NCT05593484 about?
NCT05593484 is a clinical study titled "School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska". The prevalence of childhood hearing loss in rural Alaska is disproportionately high and predominately infection-related. With preventive screenings and access to health care, much of childhood hearing loss is preventable. Although state-mandated school screening helps identify children with hearing ...
What is the current status of trial NCT05593484?
This trial is currently recruiting. It is a NA study. The enrollment target is 8,060 participants. The study started on 2023-09-01. Estimated completion is 2027-06-30.
What conditions does trial NCT05593484 study?
This clinical trial studies the following conditions: Hearing Loss.
What interventions are being tested in trial NCT05593484?
The interventions under investigation include: Standard Referral (OTHER), Specialty Telemedicine Access for Referrals (STAR) (OTHER).
Who is sponsoring clinical trial NCT05593484?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05593484 being conducted?
This trial has 1 study location across Alaska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05593484's enrollment target sits among peer trials
8,060 4th of 58 higher than 55 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06184945 · 8,100 participants · NA
Behavioral Economic & Staffing Strategies in the ICU
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI